FDA Inspection
Arthomed, LLC.Arthomed, LLC. – FDA Inspection, Jan 25, 2023
Record Details
This FDA Inspection record concerns Arthomed, LLC., with an inspection on January 25, 2023, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · a2580771-7d7e-4d89-9aeb-ee0d658ac101
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1195570
- FDA center
- Biologics
- Project area
- Human Cellular, Tissue, and Gene Therapies
Other FDA inspections of Arthomed, LLC.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| February 22, 2019 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| April 26, 2016 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| April 1, 2014 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| June 19, 2009 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Arthomed, LLC.
- FDA Inspection 1081409 - 2019-02-22
- FDA Inspection 971857 - 2016-04-26
- FDA Inspection 872590 - 2014-04-01
- FDA Inspection 590672 - 2009-06-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.